BIODEL
Biodel Inc. (Biodel) is a development-stage company. The Company is a biopharmaceutical company focused on the development and commercialization of treatments for diabetes. It develops its product candidates by applying its formulation technologies to existing drugs. Its product candidate is Linjeta. It has formulated Linjeta as rapid-acting mealtime insulin for the treatment of patients with Type I and Type II diabetes. Earlier stage product candidates include follow-on and second generation rapid-acting mealtime insulins or insulin analogs, VIAtab, a sublingual tablet formulation of insulin, a line of basal insulins, and a formulation of glucagon.
BIODEL
Social Links:
Industry:
Biotechnology Developer Platform Health Care
Founded:
2003-01-01
Address:
Danbury, Connecticut, United States
Country:
United States
Website Url:
http://www.biodel.com
Total Employee:
11+
Status:
Active
Contact:
2037965003
Email Addresses:
[email protected]
Total Funding:
48.5 M USD
Technology used in webpage:
SPF Nginx Google Maps Omniture SiteCatalyst DOSarrest Uniregistry
Similar Organizations
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
GlycoMimetics
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Immtech Pharmaceuticals
Immtech is a biopharmaceutical company focused on the discovery and commercialization of therapeutics for the treatment of patients.
Rejuvenon
Rejuvenon a biopharmaceutical company committed developing and commercializing promising compounds for treatment of oncologic diseases.
RFD Technology
RFD Technology develops and commercializes treatments for female stress urinary incontinence.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Post-IPO Equity - Biodel
Great Point Partners
Great Point Partners investment in Post-IPO Equity - Biodel
Official Site Inspections
http://www.biodel.com Semrush global rank: 3.78 M Semrush visits lastest month: 1.18 K
- Host name: a6008b9e03ae11d1d.awsglobalaccelerator.com
- IP address: 15.197.162.184
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
